Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by SSM0006on Jan 25, 2017 9:50am
136 Views
Post# 25751964

NF - NR Jan 25

NF - NR Jan 25So far, a couple of issues addressed that bashers were preying on:

1) In 2016, shareholders approved the spinoff of the Company’s Canadian operation into its own separate operating entity, to be trading under its own symbol later in 2017.  Spin Out of NHS The Company expects to complete the spin out of NHS in 2017 with shares being distributed to shareholders of record as of November 30, 2016 as soon as all the steps are completed. This is expected to take place closer to the end of Q1 as the Company is seeking to list NHS on a stock exchange. The required documents and filings are being prepared now.

2) Stakeholders will be able to get a bird’s eye view of the Oroville Property when the Company’s new video, currently under production, is released in the next few weeks.  See inside New Age Farm The Company is working on a video presentation that will showcase its operations in Oroville and give stakeholders a chance to see inside New Age Farm for the first time. The Company is also preparing a new investor presentation which will be released to our website in the coming weeks. The video and investor presentation will both be released in Q1 and we invite you to visit our website (www.newagefarminc.com) and sign up for our mailing list so you will be among the first to know when it is released.

3) NHS expects to be ready to accept licensed tenant-growers when the new laws come into force.




Bullboard Posts